Corcept Therapeutics | Attività Correnti



Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Alaunos Therapeutics USD 2.76M 795K 2024-12
ANI Pharmaceuticals USD 602.63M 66.34M 2025-06
Ardelyx USD 356.45M 72.35M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 443.11M 4.61M 2025-06
Eli Lilly USD 49.85B 8.59B 2025-06
J&J USD 71.55B 15.66B 2025-03
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Merck USD 37.07B 1.56B 2025-06
Novartis USD 25.94B 831M 2025-06
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.61M 14.35M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Supernus Pharmaceuticals USD 738.87M 51.28M 2025-06
TG Therapeutics USD 663.96M 19.45M 2025-06


Corcept Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.